Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Annovis Bio, Inc. ANVS

Full chart Compare
Set alert

Price alert · ANVS

All alert types
1.20 USD +0.11 (+10.09%)

Nov 4, 2026, 3:12 PM EST

1.10 Day range 1.25
0.93 52-week range 5.50
YTD
-65.32%
1 year
-36.51%

Financial health

Altman Z-Score

-17.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.5×
FY 2017: -95.9×FY 2018: -95.9×FY 2019: -68.5×FY 2020: -8.7×FY 2021: -9.3×FY 2022: -4.3×FY 2023: -3.0×FY 2024: -2.5×FY 2025: -2.5×
FY 2017 5y median -3.0× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 4.2×
FY 2017: -9.4×FY 2018: -8.6×FY 2019: -7.7×FY 2020: 6.3×FY 2021: 3.0×FY 2022: 3.9×FY 2023: -21.8×FY 2024: 6.6×FY 2025: 4.2×
FY 2017 5y median 3.9× FY 2025
P/FCF -2.8×
FY 2017: -122×FY 2018: -117×FY 2019: -138×FY 2020: -12.0×FY 2021: -14.7×FY 2022: -6.3×FY 2023: -4.2×FY 2024: -2.8×FY 2025: -2.8×
FY 2017 5y median -4.2× FY 2025
EV/EBITDA -1.8×
FY 2017: 150205×FY 2018: -1037317×FY 2019: -174989×FY 2020: 0.0×FY 2021: -6.1×FY 2022: -3.2×FY 2023: -2.9×FY 2024: -2.2×FY 2025: -1.8×
FY 2017 5y median -2.9× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -36.0%
FY 2017: -0.8%FY 2018: -0.9%FY 2019: -0.7%FY 2020: -8.3%FY 2021: -6.8%FY 2022: -15.8%FY 2023: -23.7%FY 2024: -35.7%FY 2025: -36.0%
FY 2017 5y median -23.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -171.2%
FY 2017: 9.8%FY 2018: 9.4%FY 2019: 11.6%FY 2020: -72.4%FY 2021: -32.6%FY 2022: -89.4%FY 2023: 725.1%FY 2024: -264.2%FY 2025: -171.2%
FY 2017 5y median -89.4% FY 2025
ROIC -170.2%
FY 2017: 515.7%FY 2018: 138.1%FY 2019: 179.7%FY 2020: -88.1%FY 2021: -32.7%FY 2022: -90.1%FY 2023: -759.6%FY 2024: -265.8%FY 2025: -170.2%
FY 2017 5y median -170.2% FY 2025
ROA -136.9%
FY 2017: -190.5%FY 2018: -1400.2%FY 2019: -88.7%FY 2020: -67.3%FY 2021: -31.5%FY 2022: -70.3%FY 2023: -550.6%FY 2024: -176.6%FY 2025: -136.9%
FY 2017 5y median -136.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -11.2%
FY 2017: 0.0%FY 2018: -4.7%FY 2019: -124.9%FY 2020: -313.5%FY 2021: -118.9%FY 2022: -75.5%FY 2023: -76.5%FY 2024: 40.7%FY 2025: -11.2%
FY 2017 FY 2025
EPS (diluted) 39.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -40.0%FY 2020: -521.4%FY 2021: -118.4%FY 2022: -63.2%FY 2023: -101.0%FY 2024: 62.9%FY 2025: 39.4%
FY 2017 FY 2025
Free Cash Flow -17.0%
FY 2017: 0.0%FY 2018: -3.9%FY 2019: 14.7%FY 2020: -733.3%FY 2021: -130.0%FY 2022: -89.6%FY 2023: -130.9%FY 2024: 45.2%FY 2025: -17.0%
FY 2017 FY 2025

Financial Health

Current Ratio 5.8×
FY 2017: 0.7×FY 2018: 0.1×FY 2019: 0.4×FY 2020: 14.0×FY 2021: 30.5×FY 2022: 4.7×FY 2023: 2.4×FY 2024: 3.6×FY 2025: 5.8×
FY 2017 5y median 4.7× FY 2025
Quick Ratio 5.8×
FY 2017: 0.7×FY 2018: 0.1×FY 2019: 371×FY 2020: 14.0×FY 2021: 30.5×FY 2022: 4.7×FY 2023: 2.4×FY 2024: 3.6×FY 2025: 5.8×
FY 2017 5y median 4.7× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2017: -802×FY 2018: 561×FY 2019: -1317×FY 2020: 0.0×FY 2021: 3.2×FY 2022: 1.1×FY 2023: 0.1×FY 2024: 0.5×FY 2025: 0.7×
FY 2017 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2017: -8119×FY 2018: -10818×FY 2019: 0.0×FY 2020: -0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -14.4×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31